---
schema_version: "secwatch.filing_event.v1"
accession: "0000950103-25-009025"
form_type: "8-K"
ticker: "AMRX"
cik: "0001723128"
company_name: "Amneal Pharmaceuticals, Inc."
filed_at: "2025-07-21T23:59:59+00:00"
generated_at: "2026-05-18T05:10:08.568529+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Amneal seeks $1.8B new term loans and $750M notes to refinance debt

## Summary
- Amneal subsidiary seeks $1.8B in new seven-year term B loans to refinance existing term loans.
- Launching $750M private offering of senior secured notes due 2032.
- Proceeds to repay existing term B loans in full and a portion of ABL borrowings.
- Notes offering not conditioned on the new term loan facility.
- Transactions subject to market conditions; no assurance of completion or final terms.

## SEC filing metadata
- accession: 0000950103-25-009025
- form_type: 8-K
- ticker: AMRX
- cik: 0001723128
- company_name: Amneal Pharmaceuticals, Inc.
- filed_at: 2025-07-21T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1723128/000095010325009025/0000950103-25-009025-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1723128/000095010325009025/dp231799_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950103-25-009025
- JSON: https://secwatch.observer/filing/0000950103-25-009025.json
- Plain text: https://secwatch.observer/filing/0000950103-25-009025.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.